Cited by 247Mental Health Treatment and AccessTreatment of Major DepressionOpioid Use Disorder Treatment

The DOI matches its Crossref record, with a small difference in title or year.

National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey

Mojtabai, Ramin, Olfson, Mark·2014·The Journal of Clinical Psychiatry

Open this paper in CoChat — free account

Abstract

Article AbstractObjective: To assess the trend in long-term use of antidepressants by persons aged ≥ 18 years, and the correlates of such use, in the United States from 1999 to 2010. Method: We examined trends in duration of antidepressant use and correlates of long-term use in data from 6 waves of the cross-sectional National Health and Nutrition Examination Survey (N = 35,379), a representative survey of the general population. Results: The overall prevalence of antidepressant use increased from 6.5% in 1999-2000 to 10.4% in 2009-2010 (odds ratio = 1.54; 95% CI, 1.31-1.81; P < .001). This included an increase from 3.0% to 6.9% in long-term use (≥ 24 months; OR = 2.12; 95% CI, 1.75-2.57; P < .001). Medium-term (6 to < 24 months; from 1.3% to 1.6%) and short-term use (< 6 months; from 2.2% to 1.8%) of antidepressants did not change appreciably in this period. The increasing trend in long-term antidepressant use was limited to adults who received their care from general medical providers (adjusted OR = 3.86; 95% CI, 2.57-5.80; P < .001). Conclusions: From 1999 to 2010, there was a marked increase in long-term use of antidepressant medications in the United States, explaining the overall increasing trend in antidepressant use. This trend calls for greater vigilance in prescribing antidepressants for long periods of time. J Clin Psychiatry © Copyright 2013 Physicians Postgraduate Press, Inc. Submitted: February 26, 2013; accepted July 9, 2013. Online ahead of print: December 10, 2013 (doi:10.4088/JCP.13m08443). Corresponding author: Ramin Mojtabai, MD, PhD, MPH, Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N Broadway, Hampton House/Room 797, Baltimore, MD 21205 (rmojtaba@jhsph.edu).

Integrity signals

Registry

Crossref · 10.4088/jcp.13m08443

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 101–200 of 246

Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method
Brišnik, V., Vukas, J., Jung‐Sievers, C., Lukaschek, K., Alexander, G. C., Thiem, U., Thürmann, P., Schüle, C., Fischer, S., Baum, E., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03397-w · Cited by 21
Derivation and validation of the Rapid Assessment of Dementia Risk (RADaR) for older adults
Capuano, A. W., Shah, R. C., Blanche, P., Wilson, R. S., Barnes, L. L., Bennett, D. A., & Arvanitakis, Z. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265379 · Cited by 18
Bone Turnover with Venlafaxine Treatment in Older Adults with Depression
Rawson, K. S., Dixon, D. J., Civitelli, R., Peterson, T. R., Mulsant, B. H., Reynolds, C. F., & Lenze, E. J. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14936 · Cited by 18
Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
Scholten, W., Batelaan, N., & Van Balkom, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320933404 · Cited by 17
Approval of psychotherapy and medication for the treatment of mental disorders over the lifespan. An age period cohort analysis
der Auwera, S. V., Schomerus, G., Baumeister, S., Matschinger, H., & Angermeyer, M. C. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015001134 · Cited by 17
Should I, can I, dare I? Patients’ view on stopping long-term antidepressant use, a qualitative study
Leeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. D., Beir, R. D., & Christiaens, T. (2022) · Acta Clinica Belgica · doi:10.1080/17843286.2021.2024384 · Cited by 17
Adherence to generic v. brand antidepressant treatment and the key role of health system factors
Barbui, C., & Conti, V. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000754 · Cited by 16
Using electronic health records to characterize prescription patterns: focus on antidepressants in nonpsychiatric outpatient settings
Deferio, J. J., Levin, T. T., Cukor, J., Banerjee, S., Abdulrahman, R., Sheth, A., Mehta, N. D., & Pathak, J. (2018) · JAMIA Open · doi:10.1093/jamiaopen/ooy037 · Cited by 15
Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the diamond longitudinal study
Coe, A., Gunn, J. M., Fletcher, S. L., Murray, E., & Kaylor‐Hughes, C. (2023) · Primary Health Care Research & Development · doi:10.1017/s1463423623000038 · Cited by 15
Longitudinal association of antidepressant medication use with metabolic syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study
Silva, M. A. D., Balkau, B., Roussel, R., Tichet, J., Fumeron, F., Fagherazzi, G., & Nabi, H. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.020 · Cited by 15
Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia
Huang, C., Yang, S.-Y., Mojtabai, R., Lin, S.-K., He, Y.-L., Chong, M., Ungvari, G. S., Tan, C., Xiang, Y., Sartorius, N., et al. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000954 · Cited by 15
Self-citation
Alcohol use disorder and treatment receipt among individuals aged 50 years and older: Other substance use and psychiatric correlates
Choi, N. G., & DiNitto, D. M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108445 · Cited by 14
The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose–response meta-analysis of epidemiological studies involving 160,727 patients
Zhuang, Y., Pang, X., Qi, Y., Zhang, T., Cao, G., Xue, H., Xu, Y., Xie, S., Liu, Y., Wang, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.939636 · Cited by 14
Factors Associated With Global Variability in Electroconvulsive Therapy Utilization
Rakita, U., Bingham, K. S., Fung, K. P.-L., & Giacobbe, P. (2017) · Journal of Ect · doi:10.1097/yct.0000000000000405 · Cited by 16
Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial
Wentink, C., Huijbers, M. J., Lucassen, P. L., Kramers, C., Akkermans, R., Adang, E., Spijker, J., & Speckens, A. E. M. (2019) · BMC Family Practice · doi:10.1186/s12875-019-0989-5 · Cited by 13
Near future ocean acidification modulates the physiological impact of fluoxetine at environmental concentration on larval urchins
Lo, H. K. A., Chua, V. A., & Chan, K. Y. K. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149709 · Cited by 13
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study
Dörks, M., Hoffmann, F., & Jobski, K. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000393 · Cited by 13
Patterns of Psychiatric Outpatient Practice in Taiwan: A Nationwide Survey
Dai, Y., Chen, M., Chen, T., & Lin, M.-H. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13100955 · Cited by 13
Uncovering antidepressant prescription patterns: a three-year analysis of outpatient trends
Karami, H., Mehrizi, R., Effatpanah, M., Rivandi, A., Daroudi, R., Armand, N., & Ghamkhar, L. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06521-z · Cited by 17
Selective serotonin reuptake inhibitors suppress sharp wave ripples in the ventral hippocampus
Shiozaki, H., Kuga, N., Kayama, T., Ikegaya, Y., & Sasaki, T. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.04.003 · Cited by 13
Does Patient Adherence to Antidepressant Medication Actually Vary Between Physicians?
Simon, G. E., Johnson, E., Stewart, C. C., Rossom, R. C., Beck, A. L., Coleman, K. J., Waitzfelder, B. E., Penfold, R. B., Operskalski, B. H., & Shortreed, S. M. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m11324 · Cited by 12
Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder
Adjei, K., Adunlin, G., & Ali, A. A. (2023) · Healthcare · doi:10.3390/healthcare11050740 · Cited by 12
Antidepressant Discontinuation Syndrome
Kim, S. H., Kim, Y. S., & Kang, U. G. (2024) · 신경정신의학 · doi:10.4306/jknpa.2024.63.2.104 · Cited by 12
Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
Kazdin, A. E., Harris, M., Hwang, I. H., Sampson, N. A., Stein, D. J., Viana, M. C., Vigo, D., Wu, C., Aguilar‐Gaxiola, S., Alonso, J., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002507 · Cited by 11
Invasive Cervical Cancer and Antidepressants
Chan, H., Hsieh, Y.-H., Lin, C.-F., Liang, H., Huang, K., Chiu, W., Lee, Y. L., McIntyre, R. S., & Chen, V. C. (2015) · Medicine · doi:10.1097/md.0000000000001866 · Cited by 11
Guidance by physicians and pharmacists during antidepressant therapy: patients’ needs and suggestions for improvement
Nederlof, M., Cath, D. C., Stoker, L. J., Egberts, T. C. G., & Heerdink, E. R. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1522-9 · Cited by 11
The emotional dance with depression: A longitudinal investigation of OULA® for depression in women
Hellem, T., Sung, Y., Ferguson, H., & Hildreth, L. A. (2020) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2020.05.007 · Cited by 11
Risk of mortality associated with concomitant antidepressant and benzodiazepine therapy among patients with depression: a population-based cohort study
Jeong, H. E., Jeon, H., Oh, I., Kim, W. J., & Shin, J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01854-w · Cited by 11
Borderline Personality and Mood Disorders
Gunderson, J. G., & Choi-Kain, L. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1314-5 · Cited by 12
The Association Between Depression and Antidepressant Use and Outcomes After Operative Treatment of Distal Radius Fractures at 1 Year
McQuillan, T. J., Bernstein, D. N., Merchan, N., Franco, J., Nessralla, C. J., Harper, C. M., & Rozental, T. D. (2022) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2022.08.018 · Cited by 10
The adverse effects of commonly used medications on male fertility: a comprehensive review
Ghomeshi, A., Yang, B., & Masterson, T. A. (2023) · F&S Reviews · doi:10.1016/j.xfnr.2023.08.001 · Cited by 10
Relationships of depressive behavior and sertraline treatment with walking speed and activity in older female nonhuman primates
Justice, J. N., Silverstein‐Metzler, M. G., Uberseder, B., Appt, S. E., Clarkson, T. B., Register, T. C., Kritchevsky, S. B., & Shively, C. A. (2017) · GeroScience · doi:10.1007/s11357-017-9999-1 · Cited by 10
Use of sequence analysis for classifying individual antidepressant trajectories to monitor population mental health
Cherrie, M. P. C., Curtis, S. E., Baranyi, G., McTaggart, S., Cunningham, N., Licence, K. A. M., Dibben, C. J. L., Bambra, C. L., & Pearce, J. R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02952-y · Cited by 11
Change in central nervous system‐active medication use following fall‐related injury in older adults
Hart, L. A., Walker, R. L., Phelan, E. A., Marcum, Z. A., Schwartz, N. R. M., Crane, P. K., Larson, E. B., & Gray, S. L. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17508 · Cited by 10
Advances in the treatment of depression
Serretti, A. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000424 · Cited by 9
Secondary Outcomes of Implemented Depression Prevention in Adolescents: A Randomized Controlled Trial
de Jonge-Heesen, K. W. J., Rasing, S. P. A., Vermulst, A. A., Scholte, R. H. J., van Ettekoven, K. M., Engels, R. C. M. E., & Creemers, D. H. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.643632 · Cited by 17
The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
Kamp, C. B., Petersen, J. J., Faltermeier, P., Juul, S., Sillassen, C. D. B., Siddiqui, F., Andersen, R. K., Moncrieff, J., Horowitz, M. A., Hengartner, M. P., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-024-06396-6 · Cited by 14
Primary care healthcare professionals supporting patients to discontinue antidepressants: A scoping review of barriers, enablers and interventions
Atkins, B., Maden, M., Birt, L., Tromans, S. J., Swithenbank, Z., Kersey, O. R., Smith, P. A., & Scott, S. (2025) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2025.02.004 · Cited by 11
Erwartungseffekte beim Absetzen von Antidepressiva
Nestoriuc, Y. (2022) · Psychotherapeut · doi:10.1007/s00278-022-00587-w · Cited by 9
Health care professional barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis
Leeuwen, E. V., Maund, E., Woods, C. J., Bowers, H. M., Christiaens, T., & Kendrick, T. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.060 · Cited by 10
The impact of β-cyclodextrin on biological and chemical properties of mianserin hydrochloride in aqueous solution
Belica, S., Miłowska, K., Йонов, М., Bryszewska, M. J., Buczkowski, A., Budryn, G., Oracz, J., Zaczyńska, D., Wróblewska, A., Urbaniak, P., et al. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113589 · Cited by 9
Suspected suicides and nonfatal suicide attempts involving antidepressants reported to United States poison control centers, 2000–2020
Francis, M., Spiller, H. A., Badeti, J., Funk, A. R., Casavant, M. J., Michaels, N. L., Zhu, M., & Smith, G. A. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2041202 · Cited by 9
Association of selective serotonin re‐uptake inhibitor (SSRI) treatment with acute substance misuse outcomes
Virtanen, S., Lagerberg, T., Khemiri, L., Suvisaari, J., Larsson, H., Lichtenstein, P., Chang, Z., & Latvala, A. (2021) · Addiction · doi:10.1111/add.15625 · Cited by 9
The assessment and aetiology of drug-induced ischaemic priapism
Moodley, D., Badenhorst, A., Choonara, Y. E., & Adam, A. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-01006-1 · Cited by 8
General Practice Patients’ Experiences and Perceptions of the WiserAD Structured Web-Based Support Tool for Antidepressant Deprescribing: Protocol for a Mixed Methods Case Study With Realist Evaluation
Coe, A., Gunn, J. M., & Kaylor‐Hughes, C. (2022) · JMIR Research Protocols · doi:10.2196/42526 · Cited by 8
Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
Wu, J., Jiao, Y., Qu, K., Yin, J., Zhu, C., & Liu, X. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1257984 · Cited by 10
Trends in hospital admissions due to antidepressant-related adverse drug events from 2001 to 2011 in the U.S.
Parihar, H. S., Yin, H., Gooch, J. L., Allen, S. N., John, S., & Xuan, J. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-1993-x · Cited by 9
Continuing versus new antidepressant use in older adults: US prescribing trends from 2006 to 2015
Rhee, T. G. (2018) · European Geriatric Medicine · doi:10.1007/s41999-018-0075-x · Cited by 8
Hidden Costs: The Clinical and Research Pitfalls of Mistaking Antidepressant Withdrawal for Relapse
Horowitz, M. A., & Davies, J. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000542437 · Cited by 7
Social media group support for antidepressant deprescribing: a mixed-methods survey of patient experiences
Coe, A., Abid, N., & Kaylor‐Hughes, C. (2024) · Australian Journal of Primary Health · doi:10.1071/py23046 · Cited by 8
Differing antidepressant maintenance methodologies
Safer, D. J. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.021 · Cited by 8
Mental Health, Human Capital and Labor Market OutcomesPreprint
Cronin, C. J., Forsstrom, M. P., & Papageorge, N. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.2896946 · Cited by 9
Improving patient experience for people prescribed medicines with a risk of dependence or withdrawal: co-designed solutions using experience based co-design
Seddon, J. L., Friedrich, C., Wadd, S., Dicks, D., Scott, S., Robinson, A., & Walker, C. (2024) · BMC Family Practice · doi:10.1186/s12875-023-02253-9 · Cited by 6
Associations between Pharmacological Treatment Patterns during the Initial Treatment Period and the Relapse or Recurrence of Anxiety Disorders: A Nationwide Retrospective Cohort Study
Kim, J., Han, C., Lee, M., Jeong, H., Kim, J., & Kim, S. (2023) · Life · doi:10.3390/life13051197 · Cited by 6
Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice
Huijbers, M. J., Wentink, C., Lucassen, P. L., Kramers, C., Akkermans, R., Spijker, J., & Speckens, A. E. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290965 · Cited by 6
Understanding Australian general practice patients’ decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach
Coe, A., Gunn, J. M., Allnutt, Z., & Kaylor‐Hughes, C. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078179 · Cited by 5
Challenges in the selection and measurement of outcomes in psychiatric trials
Juul, S., Faltermeier, P., Siddiqui, F., Petersen, J. J., Kamp, C. B., Hermann, R., Thabane, L., Moncrieff, J., Horowitz, M. A., Samaan, Z., et al. (2025) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2024-113171 · Cited by 6
Antidepressant and antipsychotic medication errors reported to United States poison control centers
Kamboj, A., Spiller, H. A., Casavant, M. J., Chounthirath, T., Michaels, N. L., & Smith, G. A. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4554 · Cited by 6
Discontinuation of long-term antidepressant use for depressive and anxiety disorders in adults
Leeuwen, E. V., van Driel, M., Sutter, A. I. D., Anderson, K., Robertson, L., & Christiaens, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495 · Cited by 5
Comparing outcomes in chronic depression following inpatient psychotherapy for patients continuing versus discontinuing antidepressant medication
Høstmælingen, A., Ulvenes, P., Nissen‐Lie, H. A., Eielsen, M., & Wampold, B. E. (2021) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2561 · Cited by 7
Trajectories of change in chronic depression: Differences in self-criticism and somatic symptoms between users of antidepressants and nonmedicated patients.
Høstmælingen, A., Ulvenes, P., Nissen‐Lie, H. A., Eielsen, M., & Wampold, B. E. (2021) · Journal of Counseling Psychology · doi:10.1037/cou0000572 · Cited by 5
Mental illness in primary care: a narrative review of patient, GP and population factors that affect prescribing rates
Tobin, H. M., Bury, G., & Cullen, W. (2018) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2018.35 · Cited by 6
National Prescribing Trends and Cost Analysis of Antidepressants, Anxiolytics, and Hypnotics in England, 2010–2023
Stedman, M., Davies, M. W., Warner-Levy, J. J., Ingram, J., Taylor, D. M., & Heald, A. H. (2025) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70011 · Cited by 5
A Holistic Self-learning Approach for Young Adult Depression and Anxiety Compared to Medication-Based Treatment-As-Usual
Hughes, S., Rondeau, M., Shannon, S. M., Sharp, J. L., Ivins, G., Lee, J., Taylor, I., & Bendixsen, B. H. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00666-9 · Cited by 5
Beneficial and harmful effects of duloxetine versus placebo, ‘active placebo’ or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Siddiqui, F., Petersen, J. J., Juul, S., Kamp, C. B., Barbateskovic, M., Moncrieff, J., Horowitz, M. A., Maagaard, M., Katakam, K. K., Gluud, C. N., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2023-082853 · Cited by 6
Caregiving at end‐of‐life: How do family structure and dementia status impact antidepressant and anxiolytic prescriptions among families?
Iacob, E., Hollingshaus, M., Utz, R., Tay, D. L., Ornstein, K. A., Alexander, R., Barrientos, P., Ellington, L., Newman, M., Belnap, T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14590 · Cited by 5
Un New Deal per le terapie psicodinamiche: lo psicoanalista come burocrate di strada
Clarke, J. C. (2024) · PSICOTERAPIA E SCIENZE UMANE · doi:10.3280/pu2024-002002 · Cited by 4
Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards
Brišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung‐Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03584-9 · Cited by 4
Unmet need for chronic mental ill health: A population-based record linkage study
Rosato, M., Tseliou, F., & O’Reilly, D. (2019) · International Journal for Population Data Science · doi:10.23889/ijpds.v4i1.1122 · Cited by 4
Evaluation of existing experimental evidence for treatment of depression in indigenous populations: A systematic review
Pollok, J., van Agteren, J. E., Chong, A., Carson‐Chahhoud, K., & Smith, B. J. (2018) · Australian Journal of Psychology · doi:10.1111/ajpy.12204 · Cited by 5
Prostate cancer and antidepressants: A nationwide population-based nested case-control study
Lin, W.-Y., Chen, V. C., Chiu, W., Yim, S. J., Ho, P. T., McIntyre, R. S., Lu, M., & Wu, S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.039 · Cited by 4
How Does the Stock Market Affect Investor Sentiment? -- Evidence from Antidepressant UsagePreprint
Liu, C. (2015) · SSRN Electronic Journal · doi:10.2139/ssrn.2691824 · Cited by 4
Untitled work
(2018) · Digital Commons - University of South Florida (University of South Florida) · Cited by 4
Mental health landscape in Kosova from 2017 to 2022: A retrospective study of antidepressant and anxiolytic market trends and the impact of COVID-19
Rugova, A., Kryeziu-Rrahmani, M., Jahiu, G., Dakaj, N., Rrahmani, F., & Kryeziu, N. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111927 · Cited by 3
Associations of antidepressant medication consumption with changes in personality pathology and quality of life among community-dwelling adults
Vittengl, J. R., Jarrett, R. B., Ro, E., & Clark, L. A. (2023) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-230016 · Cited by 3
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study
Leeuwen, E. V., Mehuys, E., Johnson, C. F. A., Keyzer, A.-S. D., Boussery, K., & Christiaens, T. C. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251333977 · Cited by 4
Conclusion: Integration and Synthesis
Choi-Kain, L. W., & Gunderson, J. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1314-5_14 · Cited by 3
Barriers and opportunities for the treatment of mild-to-moderate depression with a watchful waiting approach
Iglesias-González, M., Gil‐Girbau, M., Peñarrubia‐María, M. T., Blanco-García, E., Fernández‐Vergel, R., Serrano‐Blanco, A., Carbonell-Duacastella, C., Alonso, J., & Rubio-Valera, M. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.07.013 · Cited by 3
Treatment-Resistant Depression: An Overview
Moukaddam, N. J., & Shah, A. A. (2016) · Psychiatric Annals · doi:10.3928/00485713-20160215-01 · Cited by 3
Updating neuropathology and neuropharmacology of monoaminergic systems
Ramsay, R. R., Deurwaerdère, P. D., & Giovanni, G. D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13508 · Cited by 3
General practice management of depression among patients with coronary heart disease in Australia
Jahan, H., Bernardo, C., González‐Chica, D. A., Benson, J., & Stocks, N. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01938-x · Cited by 3
Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and SwedenPreprint
Martin, F. Z., Ahlqvist, V. H., Madley‐Dowd, P., Lundberg, M., Cohen, J. M., Furu, K., Rai, D., Forbes, H. J., Easey, K., Håberg, S. E., et al. (2024) · medRxiv · doi:10.1101/2024.10.30.24316340 · Cited by 3
Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database
Li, X., Wen, X., Fu, H., Hong, X., Lin, D., Li, X., Liang, Z., Wang, M., Yu, X., Zhou, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1700469 · Cited by 2
Identifying the underlying factors associated with antidepressant drug discontinuation: content analysis of patients’ drug reviews
Alarifi, M., Goudarzvand, S., Jabour, A. M., Foy, D., & Zolnoori, M. (2022) · Informatics for Health and Social Care · doi:10.1080/17538157.2021.2024835 · Cited by 2
Provision of Cognitive Behavior Therapy for Depression and Anxiety Disorders by Medical Student Trainees
Powell, S. K., Serafini, R. A., Frere, J. J., de Pins, A. M., Saali, A., Sultana, S., Ali, M. O., Dale, B., Datta, D., Aaronson, C. J., et al. (2023) · Academic Psychiatry · doi:10.1007/s40596-023-01873-8 · Cited by 2
Treatment of Depression in Patients on Anticoagulation Therapy: Antidepressant-Rivaroxaban Drug Interactions
Aguiar, C. C. T. (2016) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000215 · Cited by 2
A systematic review of randomized controlled trials assessing the effect of Vortioxetine on metabolic syndrome risk indicators in patients with depression
Sankar, K., Viswanathan, S., Mugundan, U. M., Nazar, R. K., Ramasamy, S., & Rajanandh, M. G. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100129 · Cited by 2
Use of antidepressant medications not associated with A1C among individuals with diabetes in NHANES sample
Kammer, J., Hosler, A. S., Leckman‐Westin, E., & DiRienzo, A. G. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.03.004 · Cited by 2
Are Antidepressants Overprescribed? Patients' Experiences of the Prescribing Process
Read, J., Cartwright, C., & Gibson, K. L. (2020) · Ethical Human Psychology and Psychiatry · doi:10.1891/ehpp-d-20-00006 · Cited by 2
Use of psychotherapy in treatment-resistant depression
Moukaddam, N., Hashmi, A. M., & Nguyen, P. (2016) · Psychiatric Annals · doi:10.3928/00485713-20160217-01 · Cited by 1
Mortality and Antidepressants Among Individuals With Autism Spectrum Disorder: A Population‐Based Cohort Study
Chen, V. C., Huang, Y., Chen, Y., Dewey, M. E., Hung, T., & Wu, S. (2026) · Autism Research · doi:10.1002/aur.70302 · Cited by 3
Hyperbolic tapering of antidepressants: where are we now?
Horowitz, M. A., & Wilcock, M. (2025) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2024.000065 · Cited by 1
Unveiling core acupoints in acupuncture treatment for primary depressive disorder: integrating data mining and network acupuncture-based analysis
Siyu, L. I. U., Xinnan, L. U. O., Jiayun, X. I. E., Miqun, Z. H. O. U., Xiaona, H. U., & Song, S. L. (2025) · Digital Chinese Medicine · doi:10.1016/j.dcmed.2025.12.006 · Cited by 2
Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK , Norway, and Sweden
Martin, F. Z., Ahlqvist, V. H., Madley‐Dowd, P., Lundberg, M., Cohen, J. M., Furu, K., Rai, D., Forbes, H. J., Easey, K., Håberg, S. E., et al. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70446 · Cited by 4
Museums as Weavers of the Invisible Strings that Connect us
Konrath, S. (2019) · Journal of the Australian Library and Information Association · doi:10.1080/24750158.2019.1670772 · Cited by 1
Serotonin Syndrome in Palliative Care #403
Chow, R., Kozhevnikov, D., & Prsic, E. H. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2020.0492 · Cited by 1
Incidence, Temporal Trends, and Socioeconomic Aspects of Acquired Male Hypogonadism
Percik, R., Vered, S., & Liel, Y. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2556-2844 · Cited by 1
Medicating and Technologizing Our Diagnosable Lives
Strong, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-56699-3_6 · Cited by 1
Changes in General Health and Mental Health Outcomes in an Urban Population Over a Decade: A Population-Representative Analysis Stratified by Sexual Orientation
Wetmore, J. B., & Jordan, A. E. (2022) · LGBT Health · doi:10.1089/lgbt.2021.0217 · Cited by 1
TRICYCLIC AND SSRI USAGE INFLUENCES THE ASSOCIATION BETWEEN BMI AND HEALTH RISK FACTORS
Carlton, K. J. (2014) · YorkSpace (York University) · Cited by 1

Authors: Mojtabai, R., & Olfson, M.
Affiliations: Johns Hopkins University (US)
Columbia University (US)
Corresponding author: Mojtabai, Ramin
ORCID: Mojtabai, Ramin
Olfson, Mark
Venue: The Journal of Clinical Psychiatry
Publisher: Physicians Postgraduate Press, Inc
Published: 2013-12-10
Volume: 75
Issue: 02
Pages: 169-177
ISSN: 0160-6689 (ISSN-L)
DOI: 10.4088/jcp.13m08443
OpenAlex: W2075265772
Cited by: 247
References: 0
Citations by year: 2026: 10 · 2025: 16 · 2024: 27 · 2023: 16 · 2022: 22 · 2021: 18 · 2020: 28 · 2019: 21 · 2018: 17 · 2017: 26 · 2016: 22 · 2015: 13 · 2014: 11
FWCI: 22.95
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (NCT01528839.)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords: antidepressant use, long-term antidepressant use, antidepressant prescribing trends, depression, general medical care, prescribing patterns, United States adults, NHANES, mental health service utilization, insurance status
MeSH terms: Adult, Aged, Antidepressive Agents, Cross-Sectional Studies, Drug Utilization, Female, Humans, Male, Middle Aged, Nutrition Surveys, Drug Prescriptions, Time Factors, United States, Prevalence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

National Trends in Long-Term Use of Antidepressant Medications: Results From the US National Health and Nutrition Examination Survey

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks